GPCRs

Can platelet purinergic receptors be targeted to safely treat non-thrombotic diseases?

  • Chair(s):

    Clive Page,
    Professor of Pharmacology,King's College London, London, United Kingdom

    Dingxin Pan,
    Postdoctoral Fellow,King's College London, London, United Kingdom

  • Session description:

    Platelet activation during inflammation and evidence for biased signalling via P2Y1
    Dr Simon Pitchford
    Senior Lecturer in Pharmacology, King's College London, London, United Kingdom

    The role of the platelet P2Y12 receptor in inflammation
    Professor Robert Storey
    Professor of Cardiology, University of Sheffield, Sheffield, United Kingdom

    Oral communication speaker - to be confirmed in 2022.

    The Role of P2Y1 and P2Y14 receptors in non-thrombotic platelet functions
    Kate Arkless
    King's College London United Kingdom, London, United Kingdom

    Novel pharmacophores and ligand docking analyses to probe P2Y1 and P2Y12 receptor activation.
    Professor Kenneth Jacobson
    National Institutes of Health, Bethesda, The United States of America

  • Sponsored by:

    the British Journal of Pharmacology

  • 00

    days

  • 00

    hours

  • 00

    minutes

  • 00

    seconds

Date

03 Jul 2023

Time

9:45 am - 12:10 pm

Speakers

Leave A Comment